UMass Medical School

Mission Statement

The UMass Center for Clinical and Translational Science (UMCCTS) was founded in 2006 to enhance clinical and translational research across the five University of Massachusetts campuses (Amherst, Boston, Dartmouth, Lowell, University of Massachusetts Medical School) and our clinical partners, UMass Memorial Medical Center and Baystate Medical Center. With the receipt of an NIH Clinical and Translational Science Award (CTSA) in 2010, and its successful renewal in 2015, the UMCCTS joined a network of NIH-funded centers collaborating to transform the conduct of clinical and translational research across the U.S. Other key partners include our patients and communities, foundations, biotechnology and pharmaceutical companies, and members of the venture capital and philanthropic communities.

At a Glance


Educational Resources Posted


Consortium News Stories Posted


Events Posted


Opportunities Posted

Coming Soon

Publications citing CTSA Program Grant


Users from Hub Registered

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2018, 2020
Page Administrators

Funding Opportunity-Point of Care Technologies

Do you have a promising point-of-care medical technology in need of further development? The NIH’s Point-of-Care Technology Research Network (POCTRN) drives the development of point-of-care technologies through collaborative efforts that merge scientific and technological capabilities with clinical


IRB Analyst

Under the direction of the Director or designee, the Internal Review Board (IRB) Analyst reviews IRB submissions ensuring efficient and effective research compliance with institutional, state and federal policies and regulations. The IRB Analyst takes a proactive role in defining, evaluating, and

Contract Administrator

We're seeking a highly motivated and dynamic Contract Administrator II to join the Medical School. The position will be primarily responsible for facilitating all aspects of the contracting and financial management for clinical research projects including reviewing of protocol documents and schedule

Improving Access to Research Among Individuals from Under-represented Racial and Ethnic Minority Communities: The Strengthening Research In Diverse Enrollment (STRIDE) Study

INTRODUCTION Under-representation in health-related research is one of a multitude of factors that contribute to health disparities experienced by African American and Latinx communities, and has been brought to the forefront in the context of the COVID-19 pandemic. Barriers to research

Novel Integrative Markers to Define Human Disease

The goal of this proposal is to establish the UMass Integrative Biomarker Center (InBioC) that will apply powerful new technologies (genomic, proteomic, metabolomic, imaging technologies, nanotechnologies) and integrative analytics to well-curated human samples in order to clarify biological